2013 American Transplant Congress
Single Dose of Rituximab Results in a Long Lasting B-Cell Depletion in Peripheral Blood, without Affecting the Peripheral T-Cell Compartment, A
The B-cell depleting antibody rituximab is widely used for the treatment of B-cell malignancies and autoimmune disorders. In organ transplantation, it is especially applied to…2013 American Transplant Congress
PD-1 Analysis on CD28-CD27- CD4 T-Cells Allows Rapid Stimulation-Independent Assessment of CMV-Viremic Episodes in Transplant Recipients
We have previously shown that a high PD-1 expression on CMV-specific CD4 T-cells defines an anergic phenotype that is associated with CMV viremia in patients…2013 American Transplant Congress
Preformed Anti-MICA Antibodies Negatively Impact Renal Allograft Evolution in Early Post-Transplantation Period
We analyzed the role of preformed a-MICA antibodies (Abs) in kidney recipients (n=727), transplanted between 2005 and 2011. Fifty two patients (pts) had preformed a-MICA…2013 American Transplant Congress
Superior Renal Function Sustained for 24 Months through Early Everolimus-Facilitated Reduction of Tacrolimus Versus Standard Tacrolimus in De Novo Liver Transplant Recipients: Results of a Randomized Trial
mTOR inhibitors have the potential to reduce calcineurin inhibitor nephrotoxicity by minimizing or eliminating the need for their use. The 12 month (M) results of…2013 American Transplant Congress
Impact of mTOR and Calcineurin Inhibition on Lipid and Glucose Metabolism – 24 Month Assessment in De Novo Liver Transplant Recipients Treated with Everolimus and Tacrolimus
For the H2304 Investigators, Hamburg, Germany; Novartis Pharma AG, Basel, Switzerland
Immunosuppressants, particularly corticosteroids (CS) and calcineurin inhibitors used after liver transplantation (LTx) can adversely affect lipid metabolism. mTOR inhibition blocks insulin-stimulated lipoprotein lipase and can…2013 American Transplant Congress
There Is No Difference in Patient Survival after Liver Transplantation between Induction with Rabbit ATG and Basiliximab in Recipients with HCV, However, There Appears To Be Less Severe Fibrosis with rATG
University of Washington, Seattle
rATG has gained acceptance for induction in liver transplantation. However, due to its strength as an immunosuppressive agent, there is concern that it may be…2013 American Transplant Congress
Soluble FGL2 Mediates Acute Rejection in Renal Allograft Recipients by Inducing Tubular Epithelial Cells Apoptosis
Background: Acute rejection (AR), initiated by infiltrating alloreactive T cells, hampers renal allograft survival. Tubular epithelial cells (TECs) are primary target in AR. TECs apoptosis…2013 American Transplant Congress
Effect of Nrf2-keap1 Pathway Activation on Human Pancreatic β Cells, The
Backgrounds: Islets are known to contain low level of antioxidants which renders them vulnerable to oxidative stress. It is also known that islets are exposed…2013 American Transplant Congress
Neutralization of Extracellular HMGB1 Suppresses Xeno-Immune Response and Delays Xenograft Rejection in a Rat-to Mouse Cardiac Xenotransplant Model
Background: Extracellular HMGB1 has been found to be a potent stimulator for adaptive immune responses. It has been reported that blockade of extracellular HMGB1 significantly…2013 American Transplant Congress
Does Extended Criteria Donor Kidney Biopsy Predict Five-Year Patient and Graft Survival?
UCLA David Geffen School of Medicine, Los Angeles, CA
Purpose: Donor biopsy is frequently used to assess extended criteria donor (ECD) organ quality, but the effect on patient survival and graft survival is less…
- « Previous Page
- 1
- …
- 60
- 61
- 62
- 63
- 64
- …
- 178
- Next Page »